Future MINDDS: Recent advances and future directions for research of Neurodevelopmental Disorders (NDD) associated with pathogenic CNV (Copy Number Variants).
A free, 3-day conference.
Date: 6-8 April 2022
Organisers: Adrian J Harwood, Yasir Syed and Marianne Van de Bree
Location: Cardiff University.
MINDDS (Maximising Impact of research in neurodevelopmental disorders) is a European COST Actionfocuses on NDD patients with pathogenic CNV (Copy Number Variants) that confer high risk for neuropsychiatric disorders, such as autism spectrum disorder (ASD) and schizophrenia. These genetic syndromes impart significant clinical and societal impact, and their study have the potential to drive major new understanding and better therapies for all NDD. This conference will describe recent advances in our understanding, including those of the MINDDS over the last 4 years, and future research directions.
The conference registration is free and is offered in two versions:
- Future MINDDS Full – Attendance to the Face-to-Face meeting and all session – register here
- Future MINDDS LITE – Access to the online (hybrid) sessions only– register here
Travel and subsistence support is available for ECRs, MINDDS Management Committee and Working Group members, and at the discretion of the organisers. Hotel list is available here.
